top of page
Asset #
Therapeutic Area
Target
Stage of Development
SG1063
Oncology
FAK/SRC
IND Ready
SG1064
Diabetes/Obesity
GLP1
Oral IND ready
SG1065
IPF
Smoothened
IND Ready
SG1066
Oncology
KRAS G12D
Phase 1
SG1067
Oncology
Brain Penetrable BTK
Phase 2
SG1068
Oncology
Pan-KRAS
Preclinical
SG1069
Pain
Nav1.8
Phase 1
SG1070
Oncology
BTK/IRAK4 degrader
Preclinical
SG1071
Immunology
TYK degrader
Preclinical
Blue Smoke

Asset Portfolio

bottom of page